The FDA is seeking information on a "large" EMR in order to research adverse drug reactions, according to a request for quotation posted May 1.
The agency's Bioinformatics and Biostatistics Division plans to use the EMR to study the "safety and surveillance of FDA regulated products," specifically targeting Department of Veterans Affairs health data to look for adverse side effects from medications.
The goal is to develop "novel data mining and data visualization" tools that can help researchers gleam insight from and apply to research. VA data is currently housed in its homegrown EMR, VistA, which the agency has been working to modernize with a switch to Cerner.
The FDA is seeking responses to the RFQ by May 14.
More articles on EHRs:
Allscripts posts $514M in Q1 revenue, up 24% from year prior: 4 things to know
VA adds medical images to patient portals
The Apple Watch project might gain a competitor — U of Kansas Medical Center to detect atrial fibrillation using Garmin's wearables